{"nct_id":"NCT03801525","title":"Study to Assess the Efficacy and Safety of Ublituximab in Combination With Umbralisib and Venetoclax Compared to Ublituximab in Combination With Umbralisib in Subjects With CLL (ULTRA-V)","status":"TERMINATED","status_verified_date":"2024-04","start_date":"2019-05-16","start_date_type":"ACTUAL","primary_completion_date":"2022-12-20","primary_completion_date_type":"ACTUAL","completion_date":"2022-12-20","completion_date_type":"ACTUAL","phases":["PHASE2","PHASE3"],"tickers":["TGTX"]}